The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patients

Neuroscience Letters

Volumn 472, Issue 3, 2010, Pages 199-203

  Valenza, A ^a   Bizzarro, A ^b   Marra, C ^b   Lauria, A ^b   Guglielmi, V ^b   Rossi, C ^b   Tiziano, F D ^b   Brahe, C ^b   Masullo, C ^b  

^a BELCOLLE HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

491 A T polymorphism; AD and neuropsychology; APOE and cognitive profile; APOE promoter and AD; APOE promoter haplotype

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC CODE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MEMORY DISORDER; ONSET AGE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VISION TEST;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; COGNITION DISORDERS; GENOTYPE; HETEROZYGOTE; HUMANS; MEMORY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 77649269836     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.02.004     Document Type: Article

References (34)

1. Alvarez-Arcaya A., Comarros O., Llorca J., Sanchez-Guerra M., Berc J., and Fernandez-Luna J.L. The -491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease. Neurosci. Lett. 304 (2001) 204-208
2. Artiga M.J., Bullido M.J., Sastre I., Requero M., Garcia M.A., Aldudo J., Vazquez J., and Valdivieso F. Allelic polymorphisms in transcriptional regulatory regiuon of Apolipoprotein E gene. FEBS Lett. 421 (1998) 105-108
3. Bahia V.S., Kok F., Marie S.N., Shinjo S.O., Caramelli P., and Nitrini R. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 22 (2008) 61-65
4. Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., and Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid beta peptide deposition. Nat. Genet. 17 (1997) 263-264
5. Bennet D.A., Wilson R.S., Schneider J.A., Evans D.A., Aggarwal N.T., Arnold S.E., Cochran E.J., Berry-Kravis E., and Bienias J.L. Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 60 (2003) 246-252
6. Bizzarro A., Seripa D., Acciarri A., Matera M.G., Pilotto A., Tiziano F.D., Brahe C., and Masullo C. The complex interaction between APOE promoter and AD: an Italian case-control study. Eur. J. Hum. Genet. 17 (2009) 938-945
7. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., and Valdivieso F. A polymorphism in the regulatory region of ApoE associated with risk for Alzheimer's dementia. Nat. Genet. 18 (1998) 69-71
8. Caltagirone C., Gainotti G., Masullo C., and Miceli G. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr. Scand. 60 (1979) 50-56
9. Carlesimo G.A., Caltagirone C., and Gainotti G. The mental deterioration battery: normative data, diagnostic reliability and quantitative analyses of cognitive impairment. Eur. Neurol. 36 (1996) 378-384
10. Casadei V.M., Ferri C., Veglia F., Gavazzi A., Salani G., Cattaneo M., Sorbi S., Annoni G., Licastro F., Mariani C., Franceschi M., and Grimaldi L.M.E. ApoE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease. Neurology 53 (1999) 1888-1889
11. Helisalmi S., Hiltunen M., Valonen P., Mannermaa A., Koivisto A.M., Lehtovirta M., Ryynanen M., and Soininen H. Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. Neurology 246 (1999) 821-824
12. Juhász A., Palotás A., Janka Z., Rimanóczy A., Palotás M., Bódi N., Boda K., Zana M., Vincze G., and Kálmán J. ApoE-491A/T promoter polymorphism is not an independent risk factor, but associated with the epsilon4 allele in Hungarian Alzheimer's dementia population. Neurochem. Res. 30 (2005) 591-596
13. Lambert J.C., Araria-Goumidi L., Myllykangas L., Ellis C., Wang J.C., Bullido M.J., Harris J.M., Artiga M.J., Hernandez D., Kwon J.M., Frigard B., Petersen R.C., Cumming A.M., Pasquier F., Sastre I., Tienari P.J., Frank A., Sulkava R., Morris J.C., St Clair D., Mann D.M., Wavrant-DeVrièze F., Ezquerra-Trabalon M., Amouyel P., Hardy J., Haltia M., Valdivieso F., Goate A.M., Pérez-Tur J., Lendon C.L., and Chartier-Harlin M.C. Contribution of ApoE promoter polymorphisms to Alzheimer's disease risk. Neurology 59 (2002) 59-66
14. Lambert J.C., Mann D., Richard F., Tian J., Shi J., Thaker U., Merrot S., Harris J., Frigard B., Iwatsubo T., Lendon C., and Amouyel P. Is there a relation between APOE expression and brain amyloid load in Alzheimer's disease?. J. Neurol. Neurosurg. Psychiatry 76 (2005) 928-933
15. Lambert J.C., Pasquier F., Cottel D., Frigard B., Amouyel P., and Chartier-Harlin M.C. A new polymorphism in the ApoE promoter associated with risk of developing Alzheimer's disease. Hum. Mol. Genet. 7 (1998) 533-540
16. Laws S.M., Clarnette R.M., Taddei K., Martins G., Paton A., Hallmayer J., Almeida O.P., Groth D.M., Gandy S.E., Forstl H., and Martins R.N. ApoE e4 and ApoE-491 A polymorphism in individuals with subjective memory loss. Mol. Psychiatry 7 (2002) 768-775
17. Laws S.M., Hone E., Taddei K., Harper C., Dean B., McClean C., Masters C., Lautenschlager N., Gandy S.E., and Martins R.N. Variation at the ApoE-491 promoter locus is associated with altered brain levels of apolipoprotein E. Mol. Psychiatry 7 (2002) 886-890
18. Laws S.M., Taddei K., Martins G., Paton A., Fisher C., Clarnette R., Hallmayer J., Brooks W.S., Gandy S.E., and Martins R.N. The -491 AA polymorphism in the ApoE gene is associated with increased plasma apoE levels in Alzheimer's disease. Neuroreport 10 (1999) 879-882
19. Marra C., Bizzarro A., Daniele A., De Luca L., Ferraccioli M., Valenza A., Brahe C., Tiziano F.D., Gainotti G., and Masullo C. Apolipoprotein E e4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 18 (2004) 125-131
20. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA work group under the auspices of department of Health and Human services task force on Alzheimer's disease. Neurology 34 (1984) 939-944
21. Mullenbach R., Lagoda P.J., and Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 5 (1989) 391
22. Neve R.L., McPhie D.L., and Chen Y. Alzheimer's disease: a dysfunction of the amyloid precursor protein. Brain Res. 886 (2000) 54-66
23. Nicodemus K.K., Stenger J.E., Schmechel D.E., Welsh-Bohmer K.A., Saunders A.M., Roses A.D., Gilbert J.R., Vance J.M., Haines J.L., Pericak-Vance M.A., and Martin E.R. Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease. Neurogenetics 5 (2004) 201-208
24. Parra-Bonilla G., Arboleda G., Yunis J., Solano E., Pardo R., Arango G., Hedmont D., and Arboleda H. Haplogroup analysis of the risk associated with APOE promoter polymorphisms (-219T/G, -491A/T and -427T/C) in Colombian Alzheimer's disease patients. Neurosci. Lett. 349 (2003) 159-162
25. Roks G., Cruts M., Bullido M.J., Backhovens H., Artica M.J., Hofman A., Valdivieso F., van Broeckhoven C., and Van Duijn C.M. The -491 A/T polymorphism in the regulatory region of the Apolipoprotein E gene and early-onset Alzheimer's disease. Neurosci. Lett. 258 (1998) 65-68
26. Roks G., Cruts M., Houwing-Duistewrmaat J.J., Dermaut B., Serneels S., Havekes L.M., Hofman A., Breteler M.M.B., van Broeckhoven C., and van Duijn C.M. Effect of the ApoE-491 A/T promoter polymorphism on Apolipoprotein E levels and risk of Alzheimer's disease: The Rotterdam Study. Am. J. Med. Genet. (Neuropsychiatric. Genet.) 114 (2002) 570-573
27. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., and Roses A.D. Association of Apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
28. Scacchi R., Gambina G., Martini M.C., Ruggeri M., Ferrari G., Silvestri M., Schiavon R., and Corbo R.M. Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern. Dement. Geriatr. Cogn. Disord. 12 (2001) 63-68
29. Song Y.Q., Rogaiva E., Premkumar S., Brindle N., Kawarai T., Orlacchio A.N., Yu G., Levesque G., Nishimura M., Ikeda M., Pei Y., O'Toole C., Duara R., Barker W., Sorbi S., Freedman M., Farrer L., and St. George-Hyslop P. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE. Neurosci. Lett. 250 (1998) 189-192
30. Strittmatter W.J., Saunders A.M., Schmechel D., Pericack-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: high aviditity binding to B amyloid and icreased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1977-1981
31. Thal D.R., Rub U., Orantes M., and Braak H. Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58 (2002) 1791-1800
32. Van Duijn C.M., Clayton D., Chandra V., Fratiglioni L., Graves A.B., Heyman A., Jorm A.F., Kokmen E., Kondo K., Mortimer J.A., Rocca W.A., Shalat S.L., Soininen H., and Hofman A. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20 (1991) S13-S20
33. Wenham P.R., Price W.H., and Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 337 (1991) 1158-1159
34. Zurutuza L., Verpillat P., Raux G., Hannequin D., Puel M., Belliard S., Michon A., Pothin Y., Camuzat A., Penet C., Martin C., Brice A., Campion D., Clerget-Darpoux F., and Frebourg T. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Eur. J. Hum. Genet. 9 (2000) 713-716